BAFMX
Price
$17.50
Change
+$0.02 (+0.11%)
Updated
Nov 18 closing price
Net Assets
46.46M
PEMGX
Price
$42.33
Change
-$0.00 (-0.00%)
Updated
Nov 18 closing price
Net Assets
30.87B
Interact to see
Advertisement

BAFMX vs PEMGX

Header iconBAFMX vs PEMGX Comparison
Open Charts BAFMX vs PEMGXBanner chart's image
Brown Advisory Mid-Cap Growth Instl
Price$17.50
Change+$0.02 (+0.11%)
VolumeN/A
Net Assets46.46M
Principal MidCap A
Price$42.33
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets30.87B
BAFMX vs PEMGX Comparison Chart in %
View a ticker or compare two or three
VS
BAFMX vs. PEMGX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAFMX is a Hold and PEMGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PEMGX has more cash in the bank: 30.9B vs. BAFMX (46.5M). BAFMX (0.00) and PEMGX (0.00) have matching dividends . BAFMX was incepted earlier than PEMGX: BAFMX (7 years) vs PEMGX (20 years). PEMGX (0.91) is less costly to investors than BAFMX (0.85). BAFMX is a more actively managed with annual turnover of: 73.00 vs. PEMGX (10.50). PEMGX has a lower initial minimum investment than BAFMX: PEMGX (1000) vs BAFMX (1000000). BAFMX annual gain was more profitable for investors over the last year : 3.25 vs. PEMGX (-6.54). PEMGX return over 5 years is better than : 24.68 vs. BAFMX (3.43).
BAFMXPEMGXBAFMX / PEMGX
Total Expense Ratio0.830.9191%
Annual Report Gross Expense Ratio0.850.9193%
Fund Existence7 years20 years-
Gain YTD3.493-0.680-513%
Front LoadN/A6%-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets46.5M30.9B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year3.25-6.54-50%
Returns for 3 years34.8832.28108%
Returns for 5 years3.4324.6814%
Returns for 10 yearsN/A89.67-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INTO0.20N/A
N/A
Initio, Inc.
BOSSY8.53N/A
N/A
Hugo Boss AG
CYDY0.29-0.03
-8.44%
CytoDyn Inc.
UPMKF25.06-4.24
-14.47%
UPM-Kymmene Corp.
OTLC0.08-0.01
-15.70%
Oncotelic Therapeutics, Inc.